106 related articles for article (PubMed ID: 25369213)
1. The symptom burden of treatment-naive patients with head and neck cancer.
Hanna EY; Mendoza TR; Rosenthal DI; Gunn GB; Sehra P; Yucel E; Cleeland CS
Cancer; 2015 Mar; 121(5):766-73. PubMed ID: 25369213
[TBL] [Abstract][Full Text] [Related]
2. High symptom burden prior to radiation therapy for head and neck cancer: a patient-reported outcomes study.
Gunn GB; Mendoza TR; Fuller CD; Gning I; Frank SJ; Beadle BM; Hanna EY; Lu C; Cleeland CS; Rosenthal DI
Head Neck; 2013 Oct; 35(10):1490-8. PubMed ID: 23169304
[TBL] [Abstract][Full Text] [Related]
3. Psychosocial consequences of head and neck cancer symptom burden after chemoradiation: a mixed-method study.
Geiss C; Hoogland AI; Arredondo B; Rodriguez Y; Bryant C; Chung CH; Patel KB; Gonzalez BD; Jim HSL; Kirtane K; Oswald LB
Support Care Cancer; 2024 Mar; 32(4):254. PubMed ID: 38538780
[TBL] [Abstract][Full Text] [Related]
4. Poor sleep quality among newly diagnosed head and neck cancer patients: prevalence and associated factors.
Santoso AMM; Jansen F; Lissenberg-Witte BI; Baatenburg de Jong RJ; Langendijk JA; Leemans CR; Smit JH; Takes RP; Terhaard CHJ; van Straten A; Verdonck-de Leeuw IM;
Support Care Cancer; 2021 Feb; 29(2):1035-1045. PubMed ID: 32566997
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and characteristics of moderate to severe fatigue: a multicenter study in cancer patients and survivors.
Wang XS; Zhao F; Fisch MJ; O'Mara AM; Cella D; Mendoza TR; Cleeland CS
Cancer; 2014 Feb; 120(3):425-32. PubMed ID: 24436136
[TBL] [Abstract][Full Text] [Related]
6. Prevalence, Severity, and Co-Occurrence of SPPADE Symptoms in 31,866 Patients With Cancer.
Kroenke K; Lam V; Ruddy KJ; Pachman DR; Herrin J; Rahman PA; Griffin JM; Cheville AL
J Pain Symptom Manage; 2023 May; 65(5):367-377. PubMed ID: 36738867
[TBL] [Abstract][Full Text] [Related]
7. A Preliminary Validation of an Optimal Cutpoint in Total Number of Patient-Reported Symptoms in Head and Neck Cancer for Effective Alignment of Clinical Resources with Patients' Symptom Burden.
Van Cleave JH; Concert C; Kamberi M; Zahriah E; Most A; Mojica J; Riccobene A; Russo N; Liang E; Hu KS; Jacobson AS; Li Z; Moses LE; Persky MJ; Persky MS; Tran T; Brody AA; Kim A; Egleston BL
Cancer Care Res Online; 2024 Jan; 4(1):. PubMed ID: 38586274
[TBL] [Abstract][Full Text] [Related]
8. Correlation between Symptom Burden and Perceived Distress in Advanced Head and Neck Cancer: A Prospective Observational Study.
Ostwal SP; Singh R; Sanghavi PR; Patel H; Anandi Q
Indian J Palliat Care; 2021; 27(3):419-425. PubMed ID: 34898935
[TBL] [Abstract][Full Text] [Related]
9. Testing Symptom Severity Thresholds and Potential Alerts for Clinical Intervention in Patients With Cancer Undergoing Chemotherapy.
Shi Q; Lee JW; Wang XS; Fisch MJ; Chang VT; Wagner L; Cleeland CS
JCO Oncol Pract; 2020 Sep; 16(9):e893-e901. PubMed ID: 32369412
[TBL] [Abstract][Full Text] [Related]
10. The impact of pretreatment symptom burden on long-term quality of life following head and neck radiation: A prospective longitudinal study.
Ladbury C; Wilde T; Amini A; Xiao Y; Maghami E; Massarelli E; Vora N; Sun V; Sampath S
Head Neck; 2024 May; ():. PubMed ID: 38817083
[TBL] [Abstract][Full Text] [Related]
11. Fatigue in lung cancer patients: symptom burden and management of challenges.
Carnio S; Di Stefano RF; Novello S
Lung Cancer (Auckl); 2016; 7():73-82. PubMed ID: 28210163
[TBL] [Abstract][Full Text] [Related]
12. Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised, controlled, open-label phase 2 trial.
Giralt J; Trigo J; Nuyts S; Ozsahin M; Skladowski K; Hatoum G; Daisne JF; Yunes Ancona AC; Cmelak A; MesÃa R; Zhang A; Oliner KS; VanderWalde A
Lancet Oncol; 2015 Feb; 16(2):221-32. PubMed ID: 25596659
[TBL] [Abstract][Full Text] [Related]
13. Treatment deintensification and symptom burden in patients with human papillomavirus-associated head and neck cancer.
Ozsahin M; Bourhis J
Cancer; 2015 Apr; 121(7):1147-8. PubMed ID: 25424190
[No Abstract] [Full Text] [Related]
14. Symptom Clusters in Head and Neck Cancer: A Systematic Review and Conceptual Model.
Mathew A; Tirkey AJ; Li H; Steffen A; Lockwood MB; Patil CL; Doorenbos AZ
Semin Oncol Nurs; 2021 Oct; 37(5):151215. PubMed ID: 34483015
[TBL] [Abstract][Full Text] [Related]
15. Frailty is an independent factor for health-related quality of life in patients with head and neck cancer receiving definitive concurrent chemoradiotherapy.
Lu CH; Hung CY; Hsueh SW; Yeh KY; Hung YS; Chou WC
Support Care Cancer; 2024 Jan; 32(2):106. PubMed ID: 38221588
[TBL] [Abstract][Full Text] [Related]
16. The female self-advocacy in Cancer Survivorship scale is a psychometrically sound measure of self-advocacy in male cancer survivors.
Thomas TH; Scott PW; Nilsen ML; Lee J; McCarthy ME; Harris A; Johnson J; Donovan HS
Psychooncology; 2024 Jan; 33(1):e6269. PubMed ID: 38095337
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of transcutaneous auricular vagus nerve stimulation on radiotherapy-related neuropathic pain in patients with head and neck cancers (RELAX): protocol for a multicentre, randomised, double-blind, sham-controlled trial.
Zuo X; Li Y; Rong X; Yang X; Zhu Y; Pan D; Li H; Shen QY; Tang Y
BMJ Open; 2023 Sep; 13(9):e072724. PubMed ID: 37730386
[TBL] [Abstract][Full Text] [Related]
18. Distinct Dysphagia Profiles in Patients With Oral Cancer After Surgery.
Mathew A; Lockwood MB; Steffen AD; Jiwan Tirkey A; Pavamani S; Patil CL; Doorenbos AZ
Oncol Nurs Forum; 2023 Feb; 50(2):201-214. PubMed ID: 37677804
[TBL] [Abstract][Full Text] [Related]
19. Dental considerations for head and neck cancer: A clinical review.
Abed H
Saudi Dent J; 2023 Jul; 35(5):476-486. PubMed ID: 37520601
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
